These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1482779)

  • 1. Does adequate control of diabetes in the preinfarction period improve the short-term postinfarction course?
    Roth A; Koffler M; Viskin S; Shargorotzki B; Bernfeld D; Laniado S
    J Diabetes Complications; 1992; 6(4):218-22. PubMed ID: 1482779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum fructosamine assay in the evaluation and follow-up of diabetics].
    Shapiro MS; Ludvinovsky S; Weiss E; Arber I
    Harefuah; 1990 Apr; 118(8):447-9. PubMed ID: 2358226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
    Malmberg K; Norhammar A; Wedel H; Rydén L
    Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators.
    Singla A; Orshaw P; Boura J; Harjai KJ
    J Interv Cardiol; 2012 Jun; 25(3):262-9. PubMed ID: 22376172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
    Timmer JR; Hoekstra M; Nijsten MW; van der Horst IC; Ottervanger JP; Slingerland RJ; Dambrink JH; Bilo HJ; Zijlstra F; van 't Hof AW
    Circulation; 2011 Aug; 124(6):704-11. PubMed ID: 21768543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preinfarction angina prevents left ventricular remodeling in patients treated with thrombolysis for myocardial infarction.
    Nesković AN; Pavlovski K; Bojić D; Popović Z; Otasević P; Vlahović A; Obradović V; Putniković B; Vasiljević-Pokrajcić Z; Bojić M; Popović AD
    Clin Cardiol; 2001 May; 24(5):364-70. PubMed ID: 11346243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.
    Stone PH; Muller JE; Hartwell T; York BJ; Rutherford JD; Parker CB; Turi ZG; Strauss HW; Willerson JT; Robertson T
    J Am Coll Cardiol; 1989 Jul; 14(1):49-57. PubMed ID: 2661630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes control among patients presenting with acute myocardial infarction in a Canadian tertiary health care setting.
    Imran SA; Cox JL; Ur E
    Can J Cardiol; 2003 Nov; 19(12):1407-10. PubMed ID: 14631475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction.
    Anzai T; Yoshikawa T; Asakura Y; Abe S; Akaishi M; Mitamura H; Handa S; Ogawa S
    J Am Coll Cardiol; 1995 Aug; 26(2):319-27. PubMed ID: 7608430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fructosamine as a screening method for diabetes mellitus in patients with suspected acute myocardial infarction.
    Kyle C; Baker J; Metcalf P; Johnson R; Norris R
    Aust N Z J Med; 1987 Oct; 17(5):467-71. PubMed ID: 3446157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control.
    Willey KA; Molyneaux LM; Yue DK
    Diabet Med; 1994; 11(7):701-4. PubMed ID: 7955998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of the determination of fructosamine in monitoring diabetic patients].
    Vinci VS; Masotti G; Citro G; De Marca S; Quaglia C; Galasso R
    Medicina (Firenze); 1990; 10(1):25-7. PubMed ID: 2381275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preinfarction angina pectoris on ST-segment resolution after primary coronary angioplasty for acute myocardial infarction.
    Takahashi T; Anzai T; Yoshikawa T; Maekawa Y; Asakura Y; Satoh T; Mitamura H; Ogawa S
    Am J Cardiol; 2002 Sep; 90(5):465-9. PubMed ID: 12208403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
    J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fructosamine (alkaline-reducing activity) for evaluation of glycemic control in diabetic patients.
    Jermendy G; Szelényi J; Bodonyi A; Földi J
    Exp Clin Endocrinol; 1988 Dec; 92(2):171-6. PubMed ID: 3243335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.